ES8800040A1 - Procedimiento para la obtencion de una composicion farmaceutica de liberacion retardada a base de 9,10-dihidro-alcaloides. - Google Patents

Procedimiento para la obtencion de una composicion farmaceutica de liberacion retardada a base de 9,10-dihidro-alcaloides.

Info

Publication number
ES8800040A1
ES8800040A1 ES551635A ES551635A ES8800040A1 ES 8800040 A1 ES8800040 A1 ES 8800040A1 ES 551635 A ES551635 A ES 551635A ES 551635 A ES551635 A ES 551635A ES 8800040 A1 ES8800040 A1 ES 8800040A1
Authority
ES
Spain
Prior art keywords
pharmaceutical
ergot alkaloid
containing compositions
dihydroergotamine
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES551635A
Other languages
English (en)
Spanish (es)
Other versions
ES551635A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB858502889A external-priority patent/GB8502889D0/en
Priority claimed from GB858517604A external-priority patent/GB8517604D0/en
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of ES8800040A1 publication Critical patent/ES8800040A1/es
Publication of ES551635A0 publication Critical patent/ES551635A0/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
ES551635A 1985-02-05 1986-02-04 Procedimiento para la obtencion de una composicion farmaceutica de liberacion retardada a base de 9,10-dihidro-alcaloides. Expired ES8800040A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB858502889A GB8502889D0 (en) 1985-02-05 1985-02-05 Co-dergocrine compositions
GB858517604A GB8517604D0 (en) 1985-07-12 1985-07-12 Dihydroergotamine compositions

Publications (2)

Publication Number Publication Date
ES8800040A1 true ES8800040A1 (es) 1987-10-16
ES551635A0 ES551635A0 (es) 1987-10-16

Family

ID=26288767

Family Applications (1)

Application Number Title Priority Date Filing Date
ES551635A Expired ES8800040A1 (es) 1985-02-05 1986-02-04 Procedimiento para la obtencion de una composicion farmaceutica de liberacion retardada a base de 9,10-dihidro-alcaloides.

Country Status (24)

Country Link
JP (1) JPS61183225A ( )
KR (1) KR920010388B1 ( )
AU (1) AU597570B2 ( )
BE (1) BE904152A ( )
CA (1) CA1263087A ( )
CH (1) CH667592A5 ( )
CY (1) CY1604A ( )
DE (1) DE3602577A1 ( )
DK (1) DK167138B1 ( )
ES (1) ES8800040A1 ( )
FR (1) FR2576787B1 ( )
GB (1) GB2170407B ( )
GR (1) GR860310B ( )
HK (1) HK57191A ( )
HU (1) HU195729B ( )
IE (1) IE59293B1 ( )
IT (1) IT1191255B ( )
LU (1) LU86289A1 ( )
NL (1) NL8600161A ( )
NZ (1) NZ215020A ( )
PH (1) PH23384A ( )
PT (1) PT81954B ( )
SE (1) SE8600496L ( )
SG (1) SG56191G ( )

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2610827B1 (fr) * 1987-02-18 1991-09-13 Pf Medicament Comprime de dihydroergotamine (d.h.e.) du type a matrice hydrophile et son procede de fabrication
SI8710406B (sl) * 1987-03-11 1998-08-31 Lek Tablete s podaljšanim delovanjem na osnovi hidroksipropilmetilceluloze z veliko molsko maso in postopek za njihovo pripravo
US7771746B2 (en) 1999-12-03 2010-08-10 Polichem Sa Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof
ES2236017T3 (es) * 1999-12-03 2005-07-16 Polichem S.A. Procedimientos para la prepaaraciones farmaceuticas de liberacion sostenida de alcaloides del ergot que tienen biodfisponibilidad mejorada y composiciones de los mismos.
NZ504526A (en) * 2000-05-12 2003-05-30 Meracol Corp Ltd Treating herpes simplex symptoms using a mixture of cetyl myristate and cetyl palmitate
CA2408541C (en) * 2000-05-12 2009-07-28 Meracol Corporation Limited Treating eczema and/or psoriasis
US20030153620A1 (en) 2000-05-12 2003-08-14 Meakin Timothy David Treating eczema and/or psoriasis
WO2001085162A1 (en) * 2000-05-12 2001-11-15 Meracol Corporation Limited Treating irritable bowel syndrome or disease
WO2003026640A1 (en) * 2001-09-28 2003-04-03 Meracol Corporation Limited Treating food allergies and/or food intolerances
CN111297815B (zh) * 2020-04-29 2022-04-15 宝利化（南京）制药有限公司 一种甲磺酸二氢麦角碱缓释片及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3147187A (en) * 1962-09-10 1964-09-01 Don Hall Lab Sustained release pharmaceutical
CH630257A5 (en) * 1975-03-17 1982-06-15 Hoffmann La Roche Sustained release formulation
DE3124983A1 (de) * 1981-06-25 1983-01-20 Meditest Inst Fuer Medizinisch Arzneiformen zur oralen verabreichung
CH649300A5 (de) * 1981-08-07 1985-05-15 Sandoz Ag Ergopeptinderivate, ihre herstellung und verwendung.
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
DE3303616A1 (de) * 1982-02-12 1983-08-25 Sandoz-Patent-GmbH, 7850 Lörrach Mutterkornalkaloide, verfahren zu deren herstellung sowie diese verbindungen enthaltende pharmazeutische zubereitungen
US4421736A (en) * 1982-05-20 1983-12-20 Merrel Dow Pharmaceuticals Inc. Sustained release diethylpropion compositions
JPS604120A (ja) * 1983-06-22 1985-01-10 Shionogi & Co Ltd 作用持続型ピナシジル製剤
GB2154874B (en) * 1984-02-29 1987-11-04 Sandoz Ltd Bromoscriptine compositions
GB8413795D0 (en) * 1984-05-30 1984-07-04 Sandoz Ltd Organic compounds

Also Published As

Publication number Publication date
IT8647620A0 (it) 1986-02-05
PH23384A (en) 1989-07-26
CH667592A5 (de) 1988-10-31
NZ215020A (en) 1989-07-27
GB8602602D0 (en) 1986-03-12
CA1263087A (en) 1989-11-21
IE59293B1 (en) 1994-02-09
FR2576787B1 (fr) 1990-01-12
DK167138B1 (da) 1993-09-06
KR920010388B1 (ko) 1992-11-27
DE3602577A1 (de) 1986-08-28
IE860291L (en) 1986-08-05
HUT41984A (en) 1987-06-29
LU86289A1 (fr) 1986-09-02
AU597570B2 (en) 1990-06-07
GR860310B (en) 1986-05-27
PT81954A (en) 1986-03-01
HK57191A (en) 1991-08-02
AU5294286A (en) 1986-08-14
BE904152A (fr) 1986-08-04
DK52086D0 (da) 1986-02-03
CY1604A (en) 1992-04-03
GB2170407B (en) 1988-10-26
NL8600161A (nl) 1986-09-01
SE8600496L (sv) 1986-08-06
PT81954B (pt) 1988-07-01
IT1191255B (it) 1988-02-24
HU195729B (en) 1988-07-28
KR860006265A (ko) 1986-09-09
DK52086A (da) 1986-08-06
ES551635A0 (es) 1987-10-16
GB2170407A (en) 1986-08-06
FR2576787A1 (fr) 1986-08-08
SG56191G (en) 1991-08-23
SE8600496D0 (sv) 1986-02-04
JPS61183225A (ja) 1986-08-15

Similar Documents

Publication Publication Date Title
AU5159490A (en) Composition and method for administration of pharmaceutically active substances
GR1003711B (el) Μεθοδος δια την παρασκευη φαρμακευτικων συνθεσεων δια συστηματικην διαδερμικην χορηγησιν.
IE860306L (en) Drug delivery system
HRP930676B1 (en) Process for the production of an active substance plaster containing estrogen
MY118371A (en) Tetrahydrolipstatin containing compositions
CA2123321A1 (en) Combination chemotherapy
DE3379496D1 (en) Constant release rate solid oral dosage formulations of cardiovascular drugs
CA2203033A1 (en) Compounds and compositions for delivering active agents
HK1004521A1 (en) Composition in the form of a foam containing 5- aminosalicylic acid for intrarectal administration
MX9500243A (es) Composicion de liberacion acelerada que contiene bromocriptina.
PT86186A (en) Process for the preparation of benzimidazol derivatives and of pharmaceutical compositions containing the same
ES8800040A1 (es) Procedimiento para la obtencion de una composicion farmaceutica de liberacion retardada a base de 9,10-dihidro-alcaloides.
GB9015914D0 (en) Heterocyclic compounds
CA2251966A1 (en) Transdermally administered dextromethorphan as antitussive agent
HUT57203A (en) Process for substituted benzimidazol and paharmaceutical composition containing them
AU3318389A (en) Azelastine-containing medicaments with controlled release of the active substance
AU5673399A (en) Compositions and methods for treating intracellular infections
AU2807689A (en) Method for the treatment of body tissues and the administration of drugs thereto
AU1950388A (en) Pharmaceutical formulation ensuring the transdermal absorption of the active ingredient and process for preparing same
ES8707488A1 (es) Un metodo para preparar maleato de 2-terc-butilamino-3'-cloropropiofenona
HUT50762A (en) Process for production of medical compositions containing as active substance derivatives of pirrol and process for production of the active substance
AU7536487A (en) A thymus derivative active after oral administration, methods of preparation and pharmaceutical compositions
HU9302813D0 (en) Pharmaceutical compositions containing new benzimidazole derivatives and process for preparing the active ingredients
EP0351876A3 (en) Composition for potentiating vaccination effect
HUT49590A (en) Process for producing benzimidazole derivatives and pharmaceutical compositions comprising same as active ingredient

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970401